Literature DB >> 26397156

Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.

Reem Abdallah1, Yin Xiong, Johnathan M Lancaster, Patricia L Judson.   

Abstract

OBJECTIVE: We evaluated complementary and alternative medicine (CAM) practices among women presenting to a National Cancer Institute-designated Comprehensive Cancer Center with a gynecologic malignancy.
METHODS: Women with a gynecologic malignancy who had consented to enrollment in our institutional prospective clinical registry between January 2003 and January 2014 and who had completed a questionnaire assessing sociodemographic characteristics, medical histories, quality of life, and CAM use were considered for analysis.
RESULTS: Among the 2508 women identified, responses to questions on CAM use were provided by 534 (21.3%). The majority of CAM question respondents were white (93.5%) and older than 50 years (76%). Overall, 464 women (87% of CAM question respondents) used at least 1 CAM therapy during the previous 12 months. The most commonly used CAM categories were biologically based approaches (83.5%), mind and body interventions (30.6%), and manipulative and body-based therapies (18.8%). The most commonly used individual CAM therapies were vitamins and minerals (78%), herbal supplements (27.9%), spiritual healing and prayer (15.1%), and deep breathing relaxation exercises (13.1%). Complementary and alternative medicine use was greatest in age groups 20 to 30 years and older than 65 years and was more prevalent among those who were widowed (P < 0.005), retired (P = 0.02), and with a higher level of education (P < 0.01). There was no association with cancer type, race, or ethnicity.
CONCLUSIONS: Complementary and alternative medicine use is common among women being treated for gynecologic malignancy. Given the potential interactions of some CAM modalities with conventional treatment and the possible benefits in controlling symptoms and improving quality of life, providers should discuss CAM with their patients.

Entities:  

Mesh:

Year:  2015        PMID: 26397156     DOI: 10.1097/IGC.0000000000000549

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.

Authors:  Yakir Segev; Ofer Lavie; Nili Stein; Walid Saliba; Noah Samuels; Eiman Shalabna; Orit Gressel Raz; Elad Schiff; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.603

2.  Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.

Authors:  Kerstin A Kessel; Sabrina Lettner; Carmen Kessel; Henning Bier; Tilo Biedermann; Helmut Friess; Peter Herrschbach; Jürgen E Gschwend; Bernhard Meyer; Christian Peschel; Roland Schmid; Markus Schwaiger; Klaus-Dietrich Wolff; Stephanie E Combs
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

3.  Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey.

Authors:  Evelyn Klein; Matthias W Beckmann; Werner Bader; Cosima Brucker; Gustav Dobos; Dorothea Fischer; Volker Hanf; Annette Hasenburg; Sebastian M Jud; Matthias Kalder; Marion Kiechle; Sherko Kümmel; Andreas Müller; Myrjam-Alice T Müller; Daniela Paepke; Andre-Robert Rotmann; Florian Schütz; Anton Scharl; Petra Voiss; Markus Wallwiener; Claudia Witt; Carolin C Hack
Journal:  Arch Gynecol Obstet       Date:  2017-06-08       Impact factor: 2.344

4.  The Use of Complementary and Alternative Medicine in Thai Gynecologic Oncology Patients: Influencing Factors.

Authors:  Nuntorn Chukasemrat; Chuenkamon Charakorn; Arb-Aroon Lertkhachonsuk
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-10       Impact factor: 2.629

5.  Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: lessons from a qualitative pilot study.

Authors:  Rachel Pozzar; Laura-Mae Baldwin; Barbara A Goff; Donna L Berry
Journal:  Pilot Feasibility Stud       Date:  2018-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.